BCV is the only therapeutic ventilation intervention that supports both inspiratory and expiratory work of breathing in a physiologically natural way, providing a real alternative to positive pressure techniques while avoiding most side effects. BCV allows patients to eat, speak and drink while their breathing is fully supported.
BCV is an important therapeutic tool that can benefit multiple organ systems, particularly in this time when positive pressure appears to be a catalyst for worsening lung disease and many systemic side effects.
Biphasic Cuirass Ventilation has many available applications with the least amount of disposable items. It allows decreased use of sedation, decreases the overall risk of hospital-acquired infections, and reduces patients’ length of stay. In the areas that drive the high costs associated with cardiopulmonary patients, BCV is a significant cost saver.
Ventilation with active exhalation means the Hayek RTX is particularly efficient for CO2 clearance. The non-mask cuirass interface allows avoidance of the side effects typically associated with facial mask or invasive positive pressure ventilation.
Learn why these medical professionals strongly believe in BCV, and let them explain the value it can bring Hospitals, ICUs, LTACHs and Home Care patients.
BCV can help manage the symptoms associated with many conditions affecting the lungs, including but not limited to ALS, COPD, ARDS And Many More!